Annual Report for the year ended 30 June 2009
Notes to the Group annual financial statements
close window  
 
Decrease font size | Increase font size | Print page | E-mail page
Current assets
 
     Notes   2009  
R’million  
  Restated  
2008  
R’million  
  Inventories   8   1 434,6     1 447,0  
  Trade and other receivables     2 091,5     1 875,8  
  Current tax assets     9,4     0,2  
  Derivative financial instruments   10   —     0,7  
  Cash and cash equivalents   11   2 065,3     1 522,2  
       5 600,8     4 845,9  
8.   INVENTORIES          
   Carrying values          
   Raw materials     450,0     505,6  
   Work-in-progress     180,9     244,8  
   Finished goods     785,1     681,6  
   Consumables     18,6     15,0  
        1 434,6     1 447,0  
   Inventories as a percentage of revenue     17%     31%  
   Inventories as a percentage of cost of sales     31%     58%  
   Write-off of inventories recognised as an expense     94,7     49,2  
   No inventories were carried at net realisable value at year-end (2008: R3,3 million).          
   No inventories were encumbered during the year.          
           
 
           
      2009  
R’million  
  Restated  
2008  
R’million  
   Impairment of inventories          
   The write-down can be split as follows          
   South Africa     74,3     49,1  
   International     20,4     0,1  
        94,7     49,2  
   The impairment relates mainly to expired inventories in the pharmaceutical segment. Due to the finite shelf life of pharmaceutical products, they are more susceptible to impairment.        
   Reconciliation of provision for impairment          
   Balance at beginning of the year     93,0     62,7  
   Raised during the year     167,7     61,1  
   Utilised during the year     (129,8)    (31,1) 
   Acquisition of subsidiary     5,5     —  
   Disposal of joint venture     (0,1)    —  
   Effects of exchange rate changes     (1,9)    0,3  
   Balance at the end of the year     134,4     93,0  
 
 
 
Back to top
| close window